Evidence map›Paper›PMID 30264483›Full record

ArticleCNS neuroscience & therapeutics2019

A single factor induces neuronal differentiation to suppress glioma cell growth.

Ji-Qiang Fu, Zhen Chen, Yong-Jia Hu, Zhao-Huan Fan, Zhen-Xing Guo, Jin-Ye Liang, Bo-Mi Ryu, Jian-Lin Ren, Xiu-Juan Shi, Jiao Li and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Biomimetic three-dimensional glioma model printedInternational journal of bioprinting · 2023
    Article
  5. Article
  6. βIII-Tubulin Gene Regulation in Health and Disease.Frontiers in cell and developmental biology · 2022
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. The Role of Neurodevelopmental Pathways in Brain Tumors.Frontiers in cell and developmental biology · 2021
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Ji-Qiang FuShanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Zhen ChenShanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Yong-Jia HuTongji University School of Medicine, Shanghai, China.
Zhao-Huan FanTongji University School of Medicine, Shanghai, China.
Zhen-Xing GuoTongji University School of Medicine, Shanghai, China.
Jin-Ye LiangTongji University School of Life Sciences and Technology, Shanghai, China.
Bo-Mi RyuShanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Jian-Lin RenShanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Xiu-Juan ShiTongji University School of Medicine, Shanghai, China.
Jiao LiTongji University School of Medicine, Shanghai, China.
Song JiaTongji University School of Medicine, Shanghai, China.
Juan WangTongji University School of Medicine, Shanghai, China.
Xiao-Si KeTongji University School of Medicine, Shanghai, China.
Xin MaTongji University School of Medicine, Shanghai, China.
Xiao TanShanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Ting ZhangCollege of Medical Technology, Zhejiang Chinese Medical University, Hangzhou, China.
Xian-Zhen ChenShanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Chen ZhangShanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.ORCID 0000-0001-8800-1320
Tongji University · CNShanghai University of Traditional Chinese Medicine · CNZhejiang Chinese Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimGlioma, with fast growth and progression features, is the most common and aggressive tumor in the central nervous system and is essentially incurable. This study is aimed at inducing neuronal differentiation to suppress glioma cell growth with a single transcription factor.

methodsOverexpression of transcription factor SRY (sex determining region Y)-box 11 (SOX11) and Zic family member 1 (ZIC1) was, respectively, performed in glioma cells with lentivirus infection. CRISPR/Cas9 technology was used to knock out ZIC1 in U87 cells, and knockout efficiency was identified by Western blotting and Sanger sequencing. Cell cycle and apoptosis were detected by flow cytometry. The downstream targets of SOX11 were analyzed by Affymetrix GeneChip microarrays. qRT-PCR and immunofluorescence technique were used to verify gene targets of genetically modified U87 cells. All the cells were imaged by a fluorescence microscope. Gene expression correlation analysis and overall survival analysis based on TCGA dataset are performed by GEPIA.

resultsWe induced glioma cells into neuron-like cells to suppress cell growth using a single transcription factor, SOX11 or ZIC1. Besides, we proved that there is a strong correlation between SOX11 and ZIC1. Our study revealed that SOX11 upregulates ZIC1 expression by binding with ZIC1 promoter, and ZIC1 partially mediates SOX11-induced neuronal differentiation in U87 cells. However, SOX11 expression is not regulated by ZIC1. Moreover, high MAP2 expression means better overall survival in TCGA lower grade glioma.

conclusionThis study revealed that glioma cells can be reprogrammed into neuron-like cells using a single factor ZIC1, which may be a potential tumor suppressor gene for gliomas treatment.

Indexed as

Cell DifferentiationCell Line, TumorCellular Reprogramming TechniquesGenes, Tumor SuppressorGliomaHEK293 CellsHumansNeuronsTranscription FactorsTranscription FactorsZIC1 protein, humancell growthgliomaneuronal differentiationreprogrammingSOX11transcription factorU87ZIC1

Identifiers

PMID30264483
PMCPMC6488917
OpenAlexW2894267687

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.